Global Markets Direct’s, ‘Galapagos NV - Product Pipeline Review - 2016’, provides an overview of the Galapagos NV’s pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Galapagos NV, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
- The report provides a snapshot of the pipeline therapeutic landscape of Galapagos NV - The report provides overview of Galapagos NV including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Galapagos NV’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Galapagos NV’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
- Evaluate Galapagos NV’s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Galapagos NV - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Galapagos NV’s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Our reports have been used by over 10K customers, including:
170 pages •
By Global Industry Analysts
• Apr 2021
- Global Optical Emission Spectroscopy (OES) Market to Reach $835.3 Million by 2027
- Amid the COVID-19 crisis, the global market for Optical Emission Spectroscopy (OES) estimated at US$594.7 Million in the year 2020, is projected to reach a revised size of US$835.3 Million by 2027, growing at aCAGR of 5%...
Report Scope: This report provides a review of various types of smart displays and their fabrication processes and identifies current and emerging applications for these products.The analyst delineates the current market status for smart displays, defines trends and presents growth forecasts for the next five years. The...
2021 Leading Biotechnology Companies SWOT Analysis--Capabilities, Goals and Strategies
This report is part of the Competitive Analysis Series prepared to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the leading...
2021 Leading Building Materials Companies SWOT Analysis--Capabilities, Goals and Strategies
In the dynamic and fragmented Building Materials industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies is particularly...
300 pages •
By The Business Research Company
• Feb 2021
Major companies in the lessors of nonfinancial intangible assets market include IBM; Qualcomm; Microsoft; Ericsson and Nokia. The global lessors of nonfinancial intangible assets market is expected to grow from $463.21 billion in 2020 to $523.17 billion in 2021 at a compound annual growth rate (CAGR) of 12.9%. The growth is mainly due...
The global aerostat systems market reached a value of US$ 9.7 Billion in 2020. Aerostats are low-level airborne systems that are used for ground supervision. They are made of large fabric envelops filled with helium or hot air and have an optimal reach of around 4,600 m in height. Aerostat systems are considered suitable for elevating light...
“LY3454738- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Chronic Spontaneous Urticaria in 7 Major Markets. A detailed picture of the LY3454738 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for...
“BI 764524 - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diabetic Retinopathy in 7 Major Markets. A detailed picture of the BI 764524 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study...
“ASN002 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Chronic Hand Eczema in 7 Major Markets. A detailed picture of the ASN002 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period...
“IONIS-PKKRx - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Hereditary Angioedema in 7 Major Markets. A detailed picture of the IONIS-PKKRx in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.